<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01619722</url>
  </required_header>
  <id_info>
    <org_study_id>PHRN10/FM-ECOPHEN</org_study_id>
    <nct_id>NCT01619722</nct_id>
  </id_info>
  <brief_title>Study of a National Cohort of Adult Patients With Phenylketonuria</brief_title>
  <acronym>ECOPHEN</acronym>
  <official_title>Study of a National Cohort of Adult Patients With Phenylketonuria</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Tours</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Tours</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Phenylketonuria (PKU) is a metabolic disease of genetic origin. This is a rare disease
      (incidence 1 / 16000 births) which is the subject of a systematic neonatal screening in
      France, because it is treatable by a diet low in phenylalanine. This plan is required upon
      confirmation of diagnosis and continued until the age of 8 years. The current trend is to
      continue the scheme at least until adolescence. Unlike other countries, in France there are
      no recommendations for a plan &quot;for life&quot;. Knowledge about the natural history of PKU in
      adulthood, the effects of pediatric age, the frequency of complicated shapes, and prognostic
      factors are poorly documented. On the other hand, there is no consensus on the therapeutic
      management of this disease in adulthood and monitoring that could be directed towards the
      detection of neurological disorders and nutrition. Social integration and quality of life of
      adults PKU patients living in France have not been studied.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim off this study is to follow a French cohort of young adult patients with PKU to:

        -  Describe the evolution of the disease in adulthood and neurological complications
           associated neuropsychological detect, investigate the prognostic factors for
           complications

        -  Describe the metabolic balance of patients

        -  Collect data on nutritional status,

        -  Detect osteoporosis

        -  Studying social integration and quality of life of adult patients with PKU

        -  Collect biological samples for further study (markers of bone turnover)

      Design:

      Cohort :

      Duration of the inclusion period: 2 years Duration of subject participation: 5 years Total
      duration of the study: 7 years

      JUDGING CRITERIA:

        -  Complications associated with PKU in adult

        -  Evolution of neuropsychometric scores

        -  Bone mineral density by densitometry

        -  Measuring the quality of life of patients
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Anticipated">February 2020</completion_date>
  <primary_completion_date type="Anticipated">February 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate a possible cognitive decline and incidence of neurological complications</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Determine the prognostic factors of neurological complications</measure>
    <time_frame>5 years</time_frame>
    <description>Determine the prognostic factors of these complications, and the impact of the disease and its management on the quality of life (SF-36) and social and professional integration of patients.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">220</enrollment>
  <condition>PKU</condition>
  <condition>Hyperphenylalaninemia</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma an serum at the beginning of study and at 5 years
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All adult patients with PKU during a consultation in Hospital care centers.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient age ≥ 18 years

          -  Phenylketonuria (PKU) or moderate persistent Hyperphenylalaninemia (HMP) diagnosed by
             neonatal screening

          -  Reading and signing an informed consent

          -  Membership of a social security system

        Exclusion Criteria:

          -  History of severe neurological definite diagnosis could interfere with the detection
             of neurological disorders associated with PKU
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>François MAILLOT, Pr</last_name>
    <role>Study Director</role>
    <affiliation>CHRU-TOURS</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHRU-Hôpital Bretonneau - Service de Médecine Interne-Nutrition</name>
      <address>
        <city>Tours</city>
        <state>Centre</state>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU-ANGERS -Médecine Interne</name>
      <address>
        <city>Angers</city>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU_Service de Médecine Interne Nutrition A2-Hôpital du Haut Levèque</name>
      <address>
        <city>Bordeaux</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU du Morvan-Département de Pédiatrie et génétique médicale,</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Femme-Mère-Enfant-Centre de Référence des Maladies Héréditaires du Métabolisme de Lyon</name>
      <address>
        <city>Bron</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Dijon--Hôpital des Enfants-Centre de Génétique</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Grenoble-Hôpital MICHALLON-Unité de Neurologie Générale</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de LILLE-Hôpital Claude HURIEZ-Service d'Endocrinologie</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>APHM-Hôpital de la Conception -Médecine Interne</name>
      <address>
        <city>Marseille</city>
        <zip>13005</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU-Service de Réanimation Pédiatrique / Néonatalogie, Consultation spécialisée en Maladies Héréditaires du Métabolisme</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Necker Enfants Malades, APHP-Maladies Métaboliques -Service de Pédiatrie</name>
      <address>
        <city>Paris</city>
        <zip>75743</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU-RENNES-Hôpital Sud-Service de Génétique-Clinique</name>
      <address>
        <city>Rennes</city>
        <zip>35203</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Rouen-Service de Pédiatrie</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de St Etienne-Hôpital Nord-Service de Pédiatrie</name>
      <address>
        <city>St-ETIENNE</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU-Toulouse-Hôpital PURPAN-Service de Médecine Interne</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of NANCY</name>
      <address>
        <city>Vandoeuvre Les Nancy</city>
        <zip>54500</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 12, 2012</study_first_submitted>
  <study_first_submitted_qc>June 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 14, 2012</study_first_posted>
  <last_update_submitted>November 15, 2016</last_update_submitted>
  <last_update_submitted_qc>November 15, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 16, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>PKU</keyword>
  <keyword>Osteoporosis</keyword>
  <keyword>HMP</keyword>
  <keyword>Life quality</keyword>
  <keyword>Neuropsychological</keyword>
  <keyword>Nutritial evaluation</keyword>
  <keyword>Phenylketonuria</keyword>
  <keyword>Hyperphenylalaninemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phenylketonurias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

